BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
South Korea · Delayed Price · Currency is KRW 13,040
-10 (-0.08%)
At close: May 14, 2026
BIO-FD&C Market Cap
BIO-FD&C has a market cap or net worth of 113.48 billion as of May 15, 2026. Its market cap has decreased by -2.10% in one year.
Market Cap
113.48B
Enterprise Value
61.07B
Revenue
19.18B
Ranking
n/a
PE Ratio
16.71
Stock Price
13,040.00
Market Cap Chart
Since February 21, 2022, BIO-FD&C's market cap has decreased from 193.04B to 113.48B, a decrease of -41.22%. That is a compound annual growth rate of -11.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 113.48B | -17.41% |
| Dec 30, 2025 | 137.39B | 14.33% |
| Dec 30, 2024 | 120.17B | -2.12% |
| Dec 28, 2023 | 122.78B | -16.94% |
| Dec 29, 2022 | 147.83B | -23.42% |
| Feb 21, 2022 | 193.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prestige Biologics | 159.78B |
| QuadMedicine | 131.93B |
| Cell Biotech | 115.59B |
| CTCBIO | 100.42B |
| NovMetaPharma | 100.16B |
| Choong Ang Vaccine Laboratory | 93.36B |
| TegoScience | 92.56B |
| SunBio,Inc. | 92.55B |